Patents Assigned to Synox Therapeutics UK Limited
  • Dosages
    Publication number: 20230340110
    Abstract: The present invention relates to a treatment regime, including an antibody or antigen-binding fragment which is capable of binding specifically to colony stimulating factor-1 receptor (CSF-1R) for use in the treatment of tenosynovial giant cell tumour (TGCT) in a subject, as well as associated uses and methods.
    Type: Application
    Filed: November 1, 2022
    Publication date: October 26, 2023
    Applicant: Synox Therapeutics UK Limited
    Inventors: Axel Mescheder, Raymond Barlow, Michael Cannarile, Georgina Meneses-Lorente